PharmD Degree Program renews accreditation through 2030

On February 7, 2022, the UCSF School of Pharmacy’s doctor of pharmacy (PharmD) degree program received its accreditation action and recommendations report from the Accreditation Council for Pharmacy Education (ACPE). ACPE found the School to be fully compliant with all 25 of its standards. The accreditation term granted for the Doctor of Pharmacy program extends until June 30, 2030, which represents the maximum eight-year cycle between self-studies.

ACPE is recognized by the U.S. Department of Education as the national agency for the accreditation of professional degree programs in pharmacy.

Per ACPE policy, a required on-site verification visit will take place at a time that is practical and with mutual agreement between ACPE and the PharmD program Dean. The purpose of the verification visit is to confirm the findings of the virtual site visit team.

Thank you to all the faculty, staff, and students whose outstanding, sustained contributions over the years were instrumental in earning the School this very favorable review, as well as to the Self-Study Steering Committee and the School of Pharmacy Leadership Group for their long-term guidance and their valuable contributions to the accreditation visit. As mentioned previously, the visiting site team commended the School for one of the most complete and readable reports they have ever received.

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.